Marksans Pharma Limited has submitted a regulatory disclosure to both BSE Limited and National Stock Exchange of India Limited regarding its participation in an investor conference.
The disclosure is made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Company officials will attend a virtual investor conference organized by Choice Institutional Equities. The conference is scheduled for Wednesday, June 10, 2026 at 03:00 PM IST.
The company explicitly states that no unpublished price sensitive information (UPSI) will be discussed during the conference.
The disclosure was signed by Harshavardhan Panigrahi, Company Secretary of Marksans Pharma Limited, on June 08, 2026 at 14:39:27 IST.